[HTML][HTML] Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf, E Jeannot… - Cancer Biology & …, 2020 - ncbi.nlm.nih.gov
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.
O Leblanc, S Vacher, C Lecerf… - Cancer Biology & …, 2020 - search.ebscohost.com
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf… - Cancer Biology & …, 2020 - search.proquest.com
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
[HTML][HTML] Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf, E Jeannot… - Cancer Biology & …, 2020 - cancerbiomed.org
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.
O Leblanc, S Vacher, C Lecerf, E Jeannot… - Cancer Biology & …, 2020 - europepmc.org
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
[PDF][PDF] Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf, E Jeannot… - Cancer, 2020 - pdfs.semanticscholar.org
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf, E Jeannot… - 2020 - hero.epa.gov
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf… - Cancer biology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
[引用][C] Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf, E Jeannot… - Cancer Biology and …, 2020 - cir.nii.ac.jp
[PDF][PDF] Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf, E Jeannot… - Cancer, 2020 - cancerbiomed.org
Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …
monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to …